The Impact of MFN Pricing on the U.S. Biosimila...

By Rene Pretorius

May 23, 2025

Could a cost-cutting policy designed to rein in drug prices backfire on biosimilar competition? The Most Favored Nation
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
Implementing Health Technology Assessment in Oman
Journavx for Pain Management: Toward Affordability and Access
Optimizing Value-Based Drug Pricing in Japan with MARIE Framework
Navigating Drug Price Regulation: Evaluating the Executive Order’s Pote...
Capivasertib Cost-Effectiveness in Advanced Breast Cancer
Advances in Colorectal Cancer Screening: Access and Cost
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...